BaroPace Receives Approval for First-in-Human Clinical Trial
BaroPace, Inc., a medical technology company dedicated to using blood pressure to regulate pacemakers for patients with heart failure with preserved ejection fraction and hypertension, announced today that it has received approval from the Central Drugs Standar



